You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenocarcinoma with other NSCLC variants

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Tumors, NSCLC, Lung Diseases Trial in Worldwide (CK-101)

Completed
  • Lung Neoplasms
  • +3 more
  • Sarasota, Florida
  • +19 more
Jul 25, 2022

Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

Recruiting
  • Lung Cancer Adenocarcinoma
  • +2 more
    • Sohag, Egypt
      Faculty of Medicine, Sohag University
    Jan 27, 2022

    Non Small Cell Lung Cancer Trial (EC145, EC145 + Docetaxel, Docetaxel)

    Completed
    • Non Small Cell Lung Cancer
    • (no location specified)
    Mar 30, 2021

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Metastatic Solid Tumor, NSCLC, Gastric Cancer Trial (RO7496353, Atezolizumab, Capecitabine)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +3 more
    • (no location specified)
    May 22, 2023

    Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • +2 more
    • Liquid biopsy
    • (no location specified)
    Jan 24, 2023

    OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

    Recruiting
    • Non-small Cell Lung Cancer
      • Santiago de Compostela, Galicia, Spain
        Luis Ángel Leon Mateos
      Oct 3, 2023

      Adenocarcinoma of the Lung Trial in Großhansdorf (nintedanib-nivolumab combination therapy)

      Active, not recruiting
      • Adenocarcinoma of the Lung
      • nintedanib-nivolumab combination therapy
      • Großhansdorf, Germany
        LungenClinic Grosshansdorf
      Dec 14, 2021

      Adenocarcinoma of Lung, Lung Cancer Trial in Minneapolis (Oral Restorative Microbiota Therapy (RMT) Capsules, Durvalumab 1500 mg

      Not yet recruiting
      • Adenocarcinoma of Lung
      • Lung Cancer
      • Oral Restorative Microbiota Therapy (RMT) Capsules
      • +3 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Apr 4, 2022

      Pancreatic Cancer Early Detection Consortium

      Recruiting
      • Pancreas Cancer
      • +3 more
        • Duarte, California
        • +29 more
        Jul 14, 2022

        NSCLC Trial in Goyang-si (BIBW 2992, simvastatin)

        Completed
        • Non-small Cell Lung Cancer
        • Goyang-si, Gyeonggi-do, Korea, Republic of
          National Cancer Center
        Apr 4, 2022

        NSCLC, Immunotherapy Trial in Ann Arbor (Dexamthasone)

        Terminated
        • Non-Small Cell Lung Cancer
        • Immunotherapy
        • Ann Arbor, Michigan
          VA Ann Arbor Healthcare System, Ann Arbor, MI
        Jan 6, 2023

        Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

        Not yet recruiting
        • Non Squamous Non Small Cell Lung Cancer
        • EGFR Positive Non-small Cell Lung Cancer
        • Toripalimab plus Chemotherapy
        • (no location specified)
        Jul 28, 2023

        NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)

        Recruiting
        • Non-small Cell Lung Cancer
        • +2 more
        • New York, New York
          Icahn School of Medicine at Mount Sinai
        Feb 8, 2022

        Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

        Recruiting
        • Acinar Cell Carcinoma
        • +93 more
        • Biospecimen Collection
        • +2 more
        • Birmingham, Alabama
        • +998 more
        Aug 23, 2022

        Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

        Recruiting
        • Solid Tumor
        • +8 more
        • TPST-1495 twice daily
        • +2 more
        • Baltimore, Maryland
        • +8 more
        Jan 4, 2023

        Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

        Not yet recruiting
        • Advanced Solid Tumors
        • Birmingham, Alabama
        • +24 more
        Aug 29, 2023

        Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation Trial in Shanghai (Furmonertinib, Bevacizumab)

        Recruiting
        • Lung Adenocarcinoma Stage III
        • +2 more
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Aug 13, 2022

        NSCLC Trial in Germany (Brigatinib, Tyrosine kinase inhibitor)

        Recruiting
        • NSCLC
        • Berlin, Germany
        • +25 more
        Nov 10, 2022

        Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)

        Terminated
        • Stage IIIA Non-Small Cell Lung Cancer
        • Cleveland, Ohio
          Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
        Dec 15, 2022

        Antrochoanal Polyp Trial in Minya (CT scan for nose and paranasal sinuses)

        Suspended
        • Antrochoanal Polyp
        • CT scan for nose and paranasal sinuses
        • Minya, Egypt
          Faculty of Medicine
        Aug 5, 2023

        Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

        Recruiting
        • Minimal Residual Disease
        • +11 more
        • ELI-002 2P
        • Duarte, California
        • +10 more
        Jan 18, 2023

        Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome Trial in Boston (Data and Specimen Collection)

        Recruiting
        • Li-Fraumeni Syndrome
        • +4 more
        • Data and Specimen Collection
        • Boston, Massachusetts
        • +2 more
        Jan 23, 2023

        NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

        Not yet recruiting
        • Non-Small Cell Lung Cancer Metastatic
        • (no location specified)
        Jan 18, 2023

        Learn About Tests Looking forGene Mutation in Lung Cancer in

        Not yet recruiting
        • Non-small Cell Lung Cancer (NSCLC)
        • No Intervention
        • Beijing, China
          Department of Pathology, National Cancer Center/National Clinica
        Feb 24, 2023